Get the Stockscreener App
492.06
1.68%
8.11
After Hours:
494.41
2.35
+0.48%
Intuitive Surgical Inc stock is traded at $492.06, with a volume of 2.03M.
It is up +1.68% in the last 24 hours and down -19.13% over the past month.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$483.95
Open:
$486
24h Volume:
2.03M
Relative Volume:
1.14
Market Cap:
$176.29B
Revenue:
$8.35B
Net Income/Loss:
$2.32B
P/E Ratio:
76.76
EPS:
6.41
Net Cash Flow:
$1.30B
1W Performance:
-1.05%
1M Performance:
-19.13%
6M Performance:
+0.42%
1Y Performance:
+26.00%
1-Day Range:
$482.80
$496.27
1-Week Range:
$474.37
$500.76
52-Week Range:
$364.17
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
492.06 | 176.29B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
231.79 | 66.56B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.87 | 44.95B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
222.05 | 32.62B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.09 | 17.41B | 17.28B | 108.00M | 391.00M | 0.20 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why - Yahoo Finance Australia
Intuitive Surgical’s Biggest Moat Is NOT What You Think – Here’s Why It’s a Game-Changer! - Smartkarma
Medical Robotics Market is expected to reach US$ 61.33 billion - openPR
US Medical Robotics Market | Growth Trends, Innovations & - openPR
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.99%: What You Should Know - MSN
This Is What Whales Are Betting On Intuitive Surgical - Benzinga
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Baird Adjusts Price Target on Intuitive Surgical to $600 From $707, Keeps Outperform Rating - Marketscreener.com
(ISRG) Technical Data - Stock Traders Daily
Intuitive Surgical, Inc. (ISRG): The Best Biotech Stock to Buy According to Billionaires - Yahoo Finance
Is Intuitive Surgical, Inc. (ISRG) a Best Biotech Stock According to Billionaires? - MSN
Robotic Rehabilitation And Assistive Technologies Market - openPR
Will ISRG Stock Drop Continue After da Vinci 5 Recall? - Yahoo Finance
Robotic Surgery Program Designated as Total Program Observation Site - Lehigh Valley Health Network
BofA Defending Intuitive Surgical (ISRG) - StreetInsider.com
Erste Group cuts Intuitive Surgical stock rating to Hold - Investing.com
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold (Friday pre-market) - StreetInsider.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com India
Intuitive Surgical price target lowered to $605 from $666 at Truist - TipRanks
Intuitive Surgical stock target cut to $605 by Truist Securities - Investing.com India
Truist Adjusts Price Target on Intuitive Surgical to $605 From $666, Maintains Buy Rating - Marketscreener.com
Intuitive Surgical Positioned for Growth Amidst Rising Adoption of Robotic Surgeries - TipRanks
Global Robotic Surgical Procedures Market to Reach $32.54B by 2034: Trends & Forecast - openPR
15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
Intuitive Surgical stock soars to all-time high of $608 - MSN
SEC Form DEF 14A filed by Intuitive Surgical Inc. - Quantisnow
Intuitive Surgical exec sells shares for $5.76 million - Investing.com India
Validea Detailed Fundamental AnalysisISRG - Nasdaq
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Intuitive Surgical’s Strong Market Position and Technological Advancements Justify Buy Rating - TipRanks
Intuitive Surgical Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts - MSN
ISRG Stock Price Falls to 200-DMA: Should You Buy, Hold or Sell? - Yahoo Finance
FDA says Intuitive da Vinci 5 foot pedal recall is Class II - Mass Device
Some medtech stocks hit by tariff turmoil more than others - Mass Device
Intuitive Surgical: Leading The Next-Generation Surgery Market (NASDAQ:ISRG) - Seeking Alpha
3 Unparalleled Growth Stocks You'll Regret Not Buying During the Nasdaq Stock Correction - The Motley Fool
Intuitive surgical EVP sells shares worth $6.37 million - Investing.com
Intuitive Surgical Executive Sells Shares Worth Over $6 Million - TradingView
10 surgical robotics companies to watch in 2025 - Robot Report
Intuitive Surgical (NasdaqGS:ISRG) Sees 10% Dip Despite Q4 Revenue Surge To US$2 Billion - Simply Wall St
Intuitive Surgical Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Intuitive Surgical Is A Sell Despite Monopoly-Like Business (NASDAQ:ISRG) - Seeking Alpha
10 surgical robotics companies you need to know - Mass Device
Intuitive Surgical, Inc. to Host Earnings Call - ACCESS Newswire
Intuitive Surgical: Getting Closer To Its Fair Value - Seeking Alpha
Healthcare Stocks To Watch Today – March 7th - Defense World
Intuitive Surgical is Known for Selling $1 Million Surgical Robots. But Here's How it Actually Makes Most of its Revenue. - MSN
Intuitive Surgical SVP sells $260,725 in stock - Investing.com India
Intuitive Surgical Stock: Is ISRG Outperforming the Healthcare Sector? - MSN
Intuitive Surgical SVP Mark Brosius sells shares worth $824,990 - Investing.com
Intuitive Surgical Executives Engage in Stock Transactions - TradingView
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):